About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 36 record(s)
Req # A-2022-004216
Provide the following BN prepared in December 2021, Auto Finance: Market trends and consumer issues. Presented to Financial Institutions Supervisory Committee Dec 15, 2021.Organization: Financial Consumer Agency of Canada
March 2022
Req # A-2022-005054
Copy of any internal and external correspondence on the matter of "Student Price Card" or "SPC" from the following individuals: Supriya Syal, Michael Olson, Ruth Stephen, Jeremie Ryan, Maria Vranas or Veronique Milot from 1 January 2021 to 21 February 2022.Organization: Financial Consumer Agency of Canada
March 2022
Req # A-2022-005056
Please provide any and all meeting summaries, reports, briefing notes, memos, placemats and decks prepared about buy now, pay later (BNPL) services in Canada, including activities, products and services by Klarna, Affirm, Paybright, Apple and Afterpay, in the period October 2021 to February 2022.Organization: Financial Consumer Agency of Canada
March 2022
Req # A-2022-005057
Please provide any and all communications, text messages, emails and meeting minutes prepared about buy now, pay later (BNPL) services in Canada, including activities, products and services by Klarna, Affirm, Paybright, Apple and Afterpay, in the period October 2021 to February 2022.Organization: Financial Consumer Agency of Canada
March 2022
Req # A-2019-00003
•All records concerning or related to the federal government’s Directive on Automated Decision-Making that was prepared by or provided to the PMPRB. (January 1, 2019 to May 2, 2019). •A list of all pending access to information requests at the PMPRB (as of May 2, 2019). •All records relating to the impact of the pending amendments on national pharmacare or the impact of national pharmacare on the pending amendments (From May 2, 2019 to March 1, 2022). •The agenda and minutes for any meetings held by PMPRB executives between January 1, 2018 and May 1, 2019 that concerned the pending amendments. •All revisions or redrafts of the Regulatory Impact Analysis Statement (date of my first request to May 2, 2019). •All records relating to the new basket of countries under the pending amendments, including the inclusion or exclusion of particular countries (date of my first request down to May 2, 2019). •All records relating to the adoption of new pricing factors under the pending amendments (date of my first request down to May 2, 2019). •All records relating to changes in the reporting requirements for patentees under the pending amendments, especially the requirement to report confidential discounts or rebates (date of my first request down to May 2, 2019). •All records relating to a possible decision to distinguish between existing and new medicines in the application of the pending regulations (whether concerning pricing rules, reporting requirements, or any other legal obligation) (date of my first request down to May 2, 2019). •All studies, reports, or other documents prepared by or held by the PMPRB which deal with changes to the content of the pending regulations or the guidelines which are being developed (date of my first request down to May 2, 2019). •All communications regarding the proposed amendments between the PMPRB and one or more of the following organizations: Health Canada, ISED, or CIPO (date of my first request down to May 2, 2019). •All letters or other communications received between September 1, 2018 and May 1, 2019 that question or criticize the pending amendments (date of my first request down to May 2, 2019). •All records generated by the PMPRB or another federal government entity that comment on or analyze the report prepared by Mr. David Dodge (August 23, 2018 to May 2, 2019). •A copy of all training presentations concerning the pending amendments that were held or were supposed to be held between Setptember 1, 2019 and May 1, 2019.Organization: Patented Medicine Prices Review Board Canada
March 2022
Req # A-2022-05127
Copies of all emails to/from Douglas Clark, Melanie Bourassa-Forcier, Tanya Potashnik and Health Canada officials from November 1, 2021 to January 31, 2022.Organization: Patented Medicine Prices Review Board Canada
March 2022
Req # A-2021-00014
Investigation materials, reports, updates, or other information related to Jonathan Pruitt, Canada 150 Research Chair at McMaster University, from September 29, 2021 to November 29, 2021.Organization: Social Sciences and Humanities Research Council of Canada
March 2022
Req # A-2020-05678
Copies of all records of submissions, feedback and other correspondence received by the PMPRB in response to consultations on the Draft Guidelines launched on November 21, 2019.Organization: Patented Medicine Prices Review Board Canada
March 2021
Req # A-2021-03053
The daily calendar of meetings, calls and other taskings for Tanya Potashnik from June 1, 2019 to February 17, 2021.Organization: Patented Medicine Prices Review Board Canada
March 2021
Req # A-2021-03054
Copies of the preparation documents, meeting summaries and emails related to the weekly meetings between Douglas Clark and Mitchell Levine from January 1, 2020 to February 17, 2021.Organization: Patented Medicine Prices Review Board Canada
March 2021